1.94k followers • 11 symbols Watchlist by Yahoo Finance
This basket consists of stocks that benefit from the needs of aging baby boomers.
The Procter & Gamble Company
UnitedHealth Group Incorporated
Royal Caribbean Cruises Ltd.
Service Corporation International
Matthews International Corporation
LifePoint Health, Inc.
Pharmaceutical company AbbVie prepared to sell one of the largest US corporate bond deals on record on Tuesday, as the company seeks to finance its takeover of former-rival Allergan. AbbVie is looking to borrow in the region of $27bn, according to people familiar with investor conversations. At that size, it will be the same size as Comcast’s $27bn bond sale in October 2018, to become the joint-fourth largest deal ever.
Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
Novo Nordisk (NVO) and Allergan (AGN) release Q3 results. FDA approves Sanofi's quadrivalent flu vaccine for older adults and Novartis' long-acting biosimilar version of Amgen's Neulasta.
Invacare (IVC) delivered earnings and revenue surprises of 28.57% and -2.17%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Botox, Juveederm fillers, Vraylar drive Allergan's (AGN) third-quarter sales, making up for loss of exclusivity on some brands and lower sales of eye drug, Restasis.
Third-quarter EPS season is in the homestretch, with blue-chip Utilities, Financial Services, Consumer and Industrial companies all releasing reports. Through 11/1/2019, Refinitiv reported that 356 S&P 500 companies have now announced 3Q earnings, with 76% coming in above consensus, ahead of the past four-quarters average percentage of 74%. The better-than-expected results have improved the overall forecast for the quarter to a -0.8%, from -3.2% at the start of the reporting season. Our analysts are always on the lookout for companies that raise their outlooks during earnings season. Management’s ability to “raise guidance” can often be a catalyst to strong returns in the quarters ahead. Following are 12 BUY-rated companies in Argus coverage for which management has raised guidance during the current EPS reporting season.
International Flavors (IFF) records growth in operating margin and generates strong free cash flow, aided by productivity savings and acquisition-related synergies in Q3.
Allergan (AGN) delivered earnings and revenue surprises of 0.00% and 4.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?